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Case Report
Aspergillus fumigatus Scleritis Associated with Monoclonal 
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A 68-year-old woman presented with pain in her left eye. Necrosis with calcium plaques was observed on the medial 
part of the sclera. Aspergillus fumigatus was isolated from the culture of the necrotic area. On systemic work-up in-
cluding serum and urine electrophoresis studies, the serum monoclonal protein of immunoglobulin G was detected. 
The patient was diagnosed with monoclonal gammopathy of undetermined significance and fungal scleritis. Despite 
intensive treatment with topical and oral antifungal agents, scleral inflammation and ulceration progressed, and 
scleral perforation and endophthalmitis developed. Debridement, antifungal irrigation, and tectonic scleral grafting 
were performed. The patient underwent a combined pars plana vitrectomy with an intravitreal injection of an anti-
fungal agent. However, scleral and intraocular inflammation progressed, and the eye was enucleated. Aspergillus 
fumigatus was isolated from the cultures of the eviscerated materials. Giemsa staining of the excised sclera showed 
numerous fungal hyphae. 
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Fungal scleritis is a rare cause of infectious scleritis that is 
associated with a poor prognosis because there is minimal 
penetration of topical and systemic antifungals into the nearly 
avascular sclera. Moreover, early diagnosis is often challenging 
because microorganisms can penetrate into the deep intra-
scleral lamellae and remain there for a long period of time 
without causing an inflammatory response [1,2]. 
Monoclonal gammopathy is defined by the presence of 
monoclonal proteins in the serum and urine. Monoclonal 
gammopathy of undetermined significance (MGUS) is a di-
agnosis given to patients with monoclonal gammopathy who 
have no features of multiple myeloma or other malignant 
disorders. Although the etiology of monoclonal gammopathy 
is not exactly known, it has been suggested that this condition 
is associated with chronic inflammation and infection [3-5]. 
Moreover, patients with monoclonal gammopathy have de-
creased productions of normal immunoglobulins and experience 
overall suppression of the immune system. Therefore, in-
fections in patients with monoclonal gammopathy require 
prompt diagnosis and appropriate treatment in order to reduce 
morbidity [6].
 
In this paper, we report a case of Aspergillus fumigatus 
scleritis in a patient with MGUS. To the best of our knowledge, 
fungal scleritis has not been previously reported in associa-
tion with MGUS.
Case Report
A 68-year-old Asian woman presented with pain and red-
ness in her left eye over the past two months. She had under-
gone a pterygium excision on the same eye three years prior 
to presentation. Otherwise, she had no history of ocular trauma 
or surgery. Her best-corrected visual acuity was 20/200 in the 
left eye. On slit lamp biomicroscopy, a nummular area of 
avascular sclera with necrosis and calcium plaque deposition 
was observed on the nasal portion of the eye. The surrounding 
vessels were engorged (Fig. 1A). Serological testing that in-
cluded antinuclear antibody, antineutrophil cytoplasmic antibody, 
angiotensin-converting enzyme, rheumatoid factor , venereal 
disease research laboratory test, and human leukocyte anti-
gen-B27 revealed no positive results. However, a reversal of 
the albumin-to-globulin ratio was noted in the serum, and a 




Fig. 1. Anterior segment photography and ultrasonography of the left eye. (A) At presentation, scleral necrosis and calcium plaque deposition 
were observed, with engorged vessels in the surrounding area. (B,C) Despite intensive medical and surgical treatments, scleral melting lead 
to perforation and progressed inferiorly into the previous scleral graft site (arrows).  (D) Scleritis progressed to endophthalmitis. Vitreal in-
flammation was found on the ultrasonography. 
serum protein electrophoresis and on immunofixation 
electrophoresis. The calcium plaque was removed, and a cul-
ture from the necrotic area was performed, which isolated 
Aspergillus fumigatus. The patient was diagnosed with fun-
gal scleritis and monoclonal gammopathy. Topical and oral 
antifungal treatments were initiated using 0.3% amphotericin 
(Fungizone
®; Bristol-Myers Squibb, New York, NY, USA) 
and 1% voriconazole (Vfend
®; Pfizer, New York, NY, USA) 
eye drops every hour and oral fluconazole 200 mg (Plunazole
®; 
Dae Woong, Seoul, Korea) daily. However, scleral necrosis 
progressed and a perforation developed. The necrotic material 
was debrided, the sclera was vigorously irrigated with am-
photericin, and tectonic scleral grafting was applied over the 
affected area. Intravenous amphotericin, 40 mg daily, was 
added to the treatment regimen. However, scleral melting 
extended into the surrounding sclera (Fig. 1B), and scleral 
perforation was found at the previous scleral graft site. 
Debridement, irrigation with amphotericin, and tectonic 
scleral grafting were repeated. Despite intensive topical and 
intravenous antifungal treatments, scleral necrosis progressed 
(Fig. 1C) and vitreous inflammation was complicated (Fig. 
1D). Under a presumed diagnosis of fungal endophthalmitis, 
we performed a pars plana vitrectomy with an intravitreal in-
jection of amphotericin (1 mg/0.1 mL, 0.1 mL).  During vi-
trectomy, we noted a large retinal inflammatory infiltrate as-
sociated with retinal edema and detachment. Scleral ulcer-
ation and intraocular inflammation progressed, and the eye 
was enucleated. Aspergillus fumigatus was isolated in the 
cultures of the eviscerated materials. Pathologic examination 
using Giemsa staining showed numerous fungal hyphae in 
the excised sclera (Fig. 2). DH Jo, et al. Aspergillus fumigatus Scleritis Associated with Monoclonal Gammopathy
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Fig. 2. Giemsa staining of the enucleated eye. Numerous fungal 
hyphae consistent with Aspergillus were observed in the excised 
sclera (arrows) (×400).
Discussion 
A diagnosis of fungal scleritis can be confirmed using 
cultures. However, the diagnosis of fungal scleritis is often 
delayed because the symptoms and signs of scleritis are difficult 
to differentiate from those of immune-mediated, necrotizing 
scleritis [1,2]. Moreover, the chronicity of the disease and the 
fungus’ slow growth and penetration in cultures complicate 
the early diagnosis of fungal scleritis [1,2]. However, be-
cause poor outcomes can result from late diagnoses, clini-
cians must have a high index of suspicion to make an early 
diagnosis of fungal scleritis in cases of necrotizing scleritis 
combined with a subconjunctival abscess or discharge, as 
well as in patients with a history of ocular trauma or surgery. 
Moreover, efforts to isolate microorganisms should be made 
by scleral biopsy, scrapings, and cultures in cases suspicious 
for fungal infection. 
For the treatment of fungal scleritis, surgical treatment can 
be used in combination with topical and systemic antifungal 
therapies [7]. Various antifungals have been used to treat fun-
gal scleritis; however, the treatment is often limited by the 
poor intraocular penetration of traditional antifungals [8]. In 
this case, we used voriconazole, which has been proven to 
have in vitro susceptibility to ocular fungal pathogens [9] and 
can achieve an effective intraocular concentration when ad-
ministered topically [10]. Surgical debridement and cry-
otherapy are reported to promote responses to antifungal 
agents, although we did not perform cryotherapy in our 
patient. It is possible that cryotherapy in our patient might 
have prevented the fungal scleritis from progressing.  
MGUS is characterized by the presence of abnormal mon-
oclonal proteins in the serum and urine. ‘Unknown sig-
nificance’ indicates that patients with MGUS alone have no 
features of multiple myeloma or other malignant disorders. 
As with our patient, MGUS patients do not show any clinical 
manifestations suggestive of multiple myeloma, including 
pathologic fracture from lytic bone lesions or renal failure 
from monoclonal proteins. However, some patients may 
eventually progress to symptomatic monoclonal gammop-
athy based on laboratory abnormalities and clinical features. 
A long-term study of MGUS patients found that approx-
imately 1% of patients developed symptomatic monoclonal 
gammopathy each year [11]. 
The etiology of monoclonal gammopathy is unknown. 
However, many studies have demonstrated that repeated
 or 
chronic stimulation of the immune system through autoimmune, 
infectious,
 or inflammatory disorders may lead to mono-
clonal gammopathy [3-5]. In our patient, MGUS was detected 
in combination with an uncontrolled scleral inflammation. 
After the inflammation was controlled by enucleation, the re-
versal of the albumin-to-globulin ratio gradually decreased. 
These findings suggest that sustained scleral inflammation 
caused by the fungal infection might have induced the mono-
clonal gammopathy in this patient. Moreover, patients with 
monoclonal gammopathy have decreased productions of 
normal immunoglobulins, which causes overall suppression 
of the immune system [6]. Therefore, the poor prognosis and 
intractable fungal scleritis in this patient might be attribut-
able to the immune-compromised state associated with the 
monoclonal gammopathy. 
In summary, we report a case of refractory fungal scleritis 
complicated by MGUS. Although rare, the possibility of the 
development of immunologic abnormalities should be con-
sidered in cases of infectious scleritis that progress despite 
intensive anti-infective chemotherapy. 
Conflict of Interest
No potential conflict of interest relevant to this article was 
reported.
References
  1.Huang FC, Huang SP, Tseng SH. Management of infectious 
scleritis after pterygium excision. Cornea 2000;19:34-9. 
  2.Fincher T, Fulcher SF. Diagnostic and therapeutic challenge of 
aspergillus flavus scleritis. Cornea 2007;26:618-20.
  3.Brown LM, Gridley G, Check D, Landgren O. Risk of multi-
ple myeloma and monoclonal gammopathy of undetermined 
significance among white and black male United States veter-
ans with prior autoimmune, infectious, inflammatory, and al-
lergic disorders. Blood 2008;111:3388-94.
  4.Garcia Marrero RD, Alonso Socas MM, Oramas Rodriguez J, 
et al. Several episodes of bacterial infections in a patient with 
monoclonal gammapathy of undetermined significance. An 
Med Interna 2006;23:452.Korean J Ophthalmol Vol.24, No.3, 2010
178
  5.Mseddi-Hdiji S, Haddouk S, Ben Ayed M, et al. Monoclonal 
gammapathies in Tunisia: epidemiological, immunochemical 
and etiological analysis of 288 cases. Pathol Biol 2005;53: 
19-25.
  6.Rajkumar SV, Dispenzieri A, Kyle RA. Monoclonal gammop-
athy of undetermined significance, Waldenstrom macro-
globulinemia, AL amyloidosis, and related plasma call dis-
corders: diagnosis and treatment. Mayo Clin Proc 2006;81: 
693-703.
  7.Rodriguez-Ares MT, De Rojas Silva MV, Pereiro M, et al. 
Aspergillus fumigatus scleritis. Acta Ophthalmol Scand 
1995;73:467-9. 
  8.Stewart RM, Quah SA, Neal TJ, Kaye SB. The use of vor-
iconazole in the treatment of Aspergillus fumigatus keratitis. 
Br J Ophthalmol 2007;91:1094-6.
  9.Marangon FB, Miller D, Giaconi JA, Alfonso EC. In vitro in-
vestigation of voriconazole susceptibility for keratitis and en-
dophthalmitis fungal pathogens. Am J Ophthalmol 2004;137: 
820-5.
10.Thiel MA, Zinkernagel AS, Burhenne J, et al. Voriconazole 
concentration in human aqueous humor and plasma during 
topical or combined topical and systemic administration for 
fungal keratitis. Antimicrob Agents Chemother 2007;51:239-44.
11. Kyle RA, Therneau TM, Rajkumar SV, et al. A long-term 
study of prognosis in monoclonal gammopathy of un-
determined significance. N Engl J Med 2002;346:564-9. 